- Associate Professor, CWRU School of Medicine
Barbara E. Shapiro, MD, PhD, is an Associate Professor of Neurology at Case Western Reserve University - University Hospitals Cleveland Medical Center. She completed her neurology residency at the Harvard Longwood Neurological Training Program in Boston, followed by fellowship training in Clinical Neurophysiology at Massachusetts General Hospital. She has previously been on staff at Tufts School of Medicine and Harvard Medical School.
Dr. Shapiro specializes in neuromuscular disorders, especially lysosomal storage disorders, and electrodiagnostic testing. Dr. Shapiro has published extensively in peer-reviewed medical journals and chapters in various neurologic textbooks. She co-authored the textbook, Electromyography and Neuromuscular Disorders, which is widely used in neurology programs in the US and abroad.
- Lysosomal Disorders
- Metabolic and Muscular Dystrophy
- Neuromuscular Disorders
- Peripheral Neuropathies
- Tay-Sachs Disease
English, French, German
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Clinical Neurophysiology
Clinical Neurophysiology - Massachusetts General Hospital (1989 - 1990)
Residency | Neurology
Neurology - Harvard Medical School Affiliated Hospitals Program (1986 - 1989)
Internship | Internal Medicine
Internal Medicine - New England Deaconess Hospital (1985 - 1986)
University Of Miami Miller School Of Medicine (1985)
Harvard University (1983)
Johns Hopkins University (1974)
Boston University (1971)
Neuromuscular Disorders, EMG and Nerve conduction studies, Late onset Tay-Sachs disease, Metabolic & Muscular Dystrophy
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Barbara Shapiro did not disclose any Outside Relationships with Industry.